Average Insider

Where insiders trade, we follow

$GRAL
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Healthcare
Sector
Medical - Diagnostics & Research
Industry
Robert Ragusa
CEO
1000
Employees
$79.37
Current Price
$3.77B
Market Cap
52W Low$30.82
Current$79.3755.2% above low, 44.8% below high
52W High$118.84

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells22$1,096,677.0012,900
1 monthBuys00--All Sells
Sells22$1,096,677.0012,900
2 monthsBuys00--All Sells
Sells22$1,096,677.0012,900
3 monthsBuys00--All Sells
Sells22$1,096,677.0012,900
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Aug 27, 2026
Ofman Joshua J.
Director
Sale5,000$85.02$425,098.00View Details
Aug 27, 2026
Freidin Aaron
Chief Financial Officer
Sale7,900$85.01$671,579.00View Details
Jun 4, 2026
Partridge Andrew John
Chief Growth Officer
Sale1,491$61.08$91,070.28View Details
31 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.7.3